TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06166732

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Music-based Mindfulness
Description: The participants will receive a single 20-minute music-based mindfulness session in person. The participants will listen to instrumental music during the session.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Control Group
Description: The participants will receive a single 20-minute information session in person. The information session will introduce the definition, history, basic concepts, and benefits of mindfulness practice.
Study: NCT05330481

Intervention type: OTHER
Intervention: Moderate-intensity (relative) exercise with glucose ingestion
Description: 120 minutes of cycling at 95% of lactate threshold ingesting 90 g/h of glucose

Intervention type: OTHER
Intervention: Moderate-intensity (relative) exercise with glucose ingestion
Description: 120 minutes of cycling at 95% of lactate threshold ingesting 90 g/h of glucose

Intervention type: OTHER
Intervention: Moderate-intensity (absolute) exercise with glucose ingestion
Description: 120 minutes of cycling at a power matched to participant in the \<70 kg body mass group, ingesting 90 g/h of glucose
Study: NCT04847076

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: m-health version of WWWT intervention
Description: m-health version of Chilean adaptation of WWWT intervention: a) Psychoeducational information for understanding and managing infant behavior and on parenting. b) Contact with the program facilitator. c) A virtual group meeting

Intervention type: OTHER
Group type: OTHER
Intervention: Treatment as usual
Description: TAU for children under one year of age include routine health checks by health professionals (nurse or doctor), every month from 0 to 4 months of age, and at 6, 8 and 12 months of age
Study: NCT06483529

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: compliance measurement
Description: compliance can be measured by analyzing pressure volume curves generated through different methods

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: compliance measurement
Description: compliance can be measured by analyzing pressure volume curves generated through different methods

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: compliance measurement
Description: compliance can be measured by analyzing pressure volume curves generated through different methods

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: compliance measurement
Description: compliance can be measured by analyzing pressure volume curves generated through different methods
Study: NCT05636423

Intervention type: OTHER
Intervention: Survey
Description: Online survey via a questionnaire composed of 28 questions.
Study: NCT05976893

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Evolocumab
Description: Evolocuma:420 mg every 4 weeks

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Statin
Description: The moderate intensity statins used during the study are one of atorvastatin 10-20mg qd, resuvastatin 5-10mg qd, and xuezhikang 0.6g bid (statin intolerance).

Intervention type: DRUG
Group type: OTHER
Intervention: Statin
Description: The moderate intensity statins used during the study are one of atorvastatin 10-20mg qd, resuvastatin 5-10mg qd, and xuezhikang 0.6g bid (statin intolerance).
Study: NCT04398407

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Coaching and Advancement for Peer Providers (CAPP)
Description: The CAPP intervention will combine executive coaching approaches and techniques with the specific needs and environmental demands of individuals working as PSS. A person who has been a PSS and trainer of PSS nationally has developed the CAPP intervention using the expertise of Center staff, the Harvard Institute of Coaching (IOC) and our Peer Advisory Group. Individuals randomized to the experimental condition will receive 16 individual coaching sessions tailored to the specific job stressors they are experiencing. CAPP is designed to address the following issues: role confusion, lack of clarity about job tasks, conflict with other providers, burnout, lack of organizational commitment and job satisfaction.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Coaching and Advancement for Peer Providers (CAPP)
Description: The CAPP intervention will combine executive coaching approaches and techniques with the specific needs and environmental demands of individuals working as PSS. A person who has been a PSS and trainer of PSS nationally has developed the CAPP intervention using the expertise of Center staff, the Harvard Institute of Coaching (IOC) and our Peer Advisory Group. Individuals randomized to the experimental condition will receive 16 individual coaching sessions tailored to the specific job stressors they are experiencing. CAPP is designed to address the following issues: role confusion, lack of clarity about job tasks, conflict with other providers, burnout, lack of organizational commitment and job satisfaction.
Study: NCT05097222

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BioFlex Dualport System
Description: The device consists of a laptop computer preprogrammed with the Bioflex® Practitioner+ Software, the Bioflex® DUO 180+ array pad that has 180 bicolour Light Emitting Diodes (LED) that emit red and near infrared light, and two laser probes, the LD-R 100 that emits red light, and the LD-I 200 that emits near infrared light.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham device
Description: Control
Study: NCT05703997

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Cyclic, 5-day calorie restriction
Description: Cyclic, 5-day, calorie-restricted (about 600 Kcal on day 1; about 300 Kcal on days 2 to 5), plant-based, low-protein, low-carbohydrate diet.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atezolizumab
Description: Atezolizumab 1200 mg administered intravenously.
Study: NCT05551312

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual Essential Newborn Care (vENC) training
Description: Essential Newborn Care Mobile Virtual Reality Simulation
Study: NCT05774743

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Consent with Visual Aid
Description: Participants who receive the study intervention will receive the standard anesthesia consent procedure with the addition of the visual aid. The visual aid is a poster with pictorial representations of the information that is verbally communicated to participants during the standard consent process.
Study: NCT05137015

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Injury prevention program
Description: The execution of the program takes 10-15 minutes. The program will be performed in the training sessions, after the usual warm-up.~The program is based on scientific evidence that has previously shown good efficacy on injury prevention in football. The exercise categories address 7 aspects:~1. Balance~2. Core stability~3. Hamstring eccentrics~4. Glute activation~5. Plyometrics~6. Running~7. Games The games are included with the aim to increase the attractiveness of the program.~Each category contains 2 exercises and the coach is free to decide which one to choose in every training session. All exercises are organized in five or six levels with increasing difficulty (physically and cognitively).
Study: NCT05856734

Intervention type: DEVICE
Intervention: Change in sleep
Description: ActiGraph GT9X Link accelerometer over 7-day. (Single measure)
Study: NCT04050358

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: NRPT
Description: Subjects randomly assigned to the active group will receive Nicotinamide Riboside and Pterostilbene (each capsule contains 125 mg NR and 25 mg PT, total daily dose is 2 capsules) for 3 weeks

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo oral capsule
Description: Subjects randomly assigned to the Placebo group will receive placebo oral capsules for 3 weeks
Study: NCT05135533

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Portable Neuromodulation Stimulation
Description: The PoNS group will receive electrical stimulation. Net direct current to the tongue electrode less than 1 µA (micro ampere) will be administered three times a week for four weeks in-lab setting, followed by three times a week for eight weeks at-home setting. Participants will continue to be enrolled in the study for additional 12 weeks without any intervention to evaluate long term effects.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham
Description: The Sham group will not receive electrical stimulation.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Gait and balance training
Description: During each session participants will receive gait training exercises for 20 minutes, 20 minutes of balance training exercises, and 20 minutes of breathing exercise three times a week for four weeks in-lab setting. This will be followed by 20 minutes of gait training exercises, 20 minutes of balance training exercises, and 20 minutes of breathing exercise three times a week for eight weeks at-home setting. Participants will continue to be enrolled in the study for additional 12 weeks without any intervention to evaluate long term effects.

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Gait and balance training
Description: During each session participants will receive gait training exercises for 20 minutes, 20 minutes of balance training exercises, and 20 minutes of breathing exercise three times a week for four weeks in-lab setting. This will be followed by 20 minutes of gait training exercises, 20 minutes of balance training exercises, and 20 minutes of breathing exercise three times a week for eight weeks at-home setting. Participants will continue to be enrolled in the study for additional 12 weeks without any intervention to evaluate long term effects.
Study: NCT06381765

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: ultrasound guided Serratus plane bock and pectointercostal block
Description: ultrasound guided serratus plane block (20 ml 0,25 %bupivacaine) will perform at the midaxillary 5.th rib and pectointercostal plane block (0,25% bupivacaine 15 ml) will perform at 4-5.th intercostal space. Both 2 blocks will perform bilaterally

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: ultrasound guided Serratus plane bock
Description: ultrasound guided serratus plane block (20 ml 0,25 %bupivacaine) will perform at the midaxillary 5.th rib to the all patients
Study: NCT05830812

Intervention type: DIAGNOSTIC_TEST
Intervention: Invasiveness diagnosis
Description: To predict the invasiveness of patients with small-sized lung adenocarcinoma intraoperatively based on multi-modal information.

Intervention type: DIAGNOSTIC_TEST
Intervention: Invasiveness diagnosis
Description: To predict the invasiveness of patients with small-sized lung adenocarcinoma intraoperatively based on multi-modal information.

Intervention type: DIAGNOSTIC_TEST
Intervention: Invasiveness diagnosis
Description: To predict the invasiveness of patients with small-sized lung adenocarcinoma intraoperatively based on multi-modal information.
Study: NCT04971161

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: allo-APZ2-CVU
Description: Suspension of ABCB5-positive dermal mesenchymal stromal cells. One topical application with a syringe.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: allo-APZ2-CVU
Description: Suspension of ABCB5-positive dermal mesenchymal stromal cells. One topical application with a syringe.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: allo-APZ2-CVU
Description: Suspension of ABCB5-positive dermal mesenchymal stromal cells. One topical application with a syringe.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: One topical application with a syringe
Study: NCT06329817

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Incidence of regurgitation in two different position.
Description: Preventing aspiration pneumonia in general anaesthesia in two different position supine v/s semi - Fowler

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Incidence of regurgitation in two different position.
Description: Preventing aspiration pneumonia in general anaesthesia in two different position supine v/s semi - Fowler
Study: NCT06407726

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: virtual reality training group
Description: Participants will receive 40-minute sessions five days per week for six weeks of Virtual Reality intervention and conventional therapy.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: vestibular exercise group
Description: Participants will receive 40-minute sessions five days per week for six weeks of Vestibular Exercises and conventional therapy.
Study: NCT05620628

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Durvalumab
Description: Durvalumab will be administered at 1500mg every 4 weeks from cycles 1 day 1.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Savolitinib
Description: Savoritinib 600mg will be administered orally a day for 28 days as one cycle.
Study: NCT05890729

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XTMAB-16 or Placebo
Description: Infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XTMAB-16 or Placebo
Description: Infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XTMAB-16 or Placebo
Description: Infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XTMAB-16 or Placebo
Description: Infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XTMAB-16 or Placebo
Description: Infusion
Study: NCT05735743

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivational interviewing
Description: In this trial, motivational interviewing (MI) is the intervention. The MI sessions will embody the spirit of MI (PACE - Partnership, Acceptance, Compassion and Evocation) and the use of MI strategies (OARS - Open-ended questions, Affirmations, Reflections and Summaries) and MI communication processes (engagement, focusing, evoking and planning).
Study: NCT04569240

Intervention type: DEVICE
Group type: OTHER
Intervention: Dexcom G6 continuous glucose monitor
Description: Dexcom G6 continuous glucose monitor will be applied to the upper outer arm before cardiovascular surgery. Data will be collected for 10 days or upon discharge from the ICU.
Study: NCT06580704

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lumbosacral Erector Spinae Plane Block
Description: Patients will receive ultrasound-guided lumbosacral erector spinae plane block.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Psoas Muscle Compartment With Sciatic Nerve Block
Description: Patients will receive ultrasound-guided psoas muscle compartment with sciatic nerve block.
Study: NCT05740254

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Early Time Restricted Eating
Description: Early Time Restricted Eating 7 AM to 3 PM

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Late Time Restricted Eating
Description: Late Time Restricted Eating 12 PM to 8 PM
Study: NCT05901298

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: My Breastfeeding Guide
Description: Development of the content of the mobile nursing application had began with a literature review on breastfeeding, Dennis' Breastfeeding Self-Efficacy Theory and Pender's Health Promotion Model and after content is created. The mobile nursing application can be download via the Google Play Store® and the Apple Store®. The application consist of three parts. In the first part includes mother and baby information which is asked with scales and forms, the second part includes literature knowledge and the third section includes the expert consultation and blog section. Mothers receive notifications consisting of sentences every two days to increase their breastfeeding self-efficacy. The application web page can allow the mothers' information to be kept in the system.
Study: NCT05728411

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Remote foot temperature monitoring system
Description: Remote temperature monitoring involves a thermometric mat that can detect hot spots on the plantar surface of the foot. The mat has embedded cellular connectivity so that data can be transmitted from the patient's home to the company, where the temperature data can be analyzed. The company has a team of health coaches that work with patients and providers to detect signs of damage early in order to prevent ulceration.

Intervention type: OTHER
Group type: OTHER
Intervention: Enhanced usual care
Description: Usual care is based on the VA's amputation prevention program (PAVE - Preventing Amputation in Veterans Everywhere - VHA Directive 1410), which provides a model of care for patients at risk for amputation as well as patients who have already undergone an amputation.~Usual care will be enhanced by providing resources (e.g., information through written newsletters) relevant to a population of Veterans with diabetes, including information on nutrition and cooking, physical activities, and whole health opportunities

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Enhanced usual care
Description: Usual care is based on the VA's amputation prevention program (PAVE - Preventing Amputation in Veterans Everywhere - VHA Directive 1410), which provides a model of care for patients at risk for amputation as well as patients who have already undergone an amputation.~Usual care will be enhanced by providing resources (e.g., information through written newsletters) relevant to a population of Veterans with diabetes, including information on nutrition and cooking, physical activities, and whole health opportunities
Study: NCT05227417

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SMS
Description: Weekly text messages that will be sent automatically by a web-based system to participants' cell-phones. Participants will be able to respond and messages will reach the system. The health providers will be in charge to respond (from the web system) to participants who reply asking for support or any other request.
Study: NCT04984616

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 40 mg Atorvastatin/day for 120 days P.O.
Description: Oral administration of Atorvastatin 40 mg/daily for 120 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atorvastatin 80
Description: Oral administration of Atorvastatin 80 mg/daily for 120 days

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Oral administration of Placebo daily for 120 days
Study: NCT05908916

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AtezoBev with combined radiotherapy
Description: Atezolizumab (1200mg) and Bevacizumab (15mg/kg) are administered to patients once for each cycle with 3-week intervals, and additional radiotherapy (iGTV 50-60 Gy, CTV 40Gy, PTV 30Gy / 10Fx) for the mass or portal vein tumor thrombosis is performed before second cycle of AtezoBev.
Study: NCT04645355

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Guselkumab
Description: All subjects will initially be treated with guselkumab 100 mg SQ at weeks 0, 4, and then every 8 weeks thereafter until week 44

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Guselkumab
Description: All subjects will initially be treated with guselkumab 100 mg SQ at weeks 0, 4, and then every 8 weeks thereafter until week 44
Study: NCT06159790

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GME751
Description: Drug: GME751 Concentrate for solution for infusion, Biologic, Liquid in vial, 100 mg, 200 mg every 3 weeks, i.v. infusion Drug: Pemetrexed (i.v. infusion) Drug: Carboplatin or Cisplatin (i.v. infusion)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Keytruda-EU
Description: Drug: Keytruda-EU Concentrate for solution for infusion, biologic, liquid in vial, 100 mg, 200mg every 3 weeks, i.v. infusion Drug: Pemetrexed (i.v. infusion) Drug: Carboplatin or Cisplatin (i.v. infusion)
Study: NCT06419465

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Peer-Led Health Protection and Promotion Training Program
Description: Multiple teaching methods will be used throughout 12 weeks; interactive group trainings on health protection and promotion issues and health seeking behavior methods, demonstration and demonstration using Google Fit and E-Nabiz mobile applications and downloading the applications to their phones, establishing WhatsApp groups to interact with peers, encouraging physical activity using the Google Fit mobile application. In order to provide social interaction, walking with peer leaders, health protection and development issues, receiving questions and opinions and giving guidance by individual phone calls regarding E-Nabiz and Google Fit mobile applications, holding peer group meetings and any of the Health Protection and Development Training Program targets. It consists of interventions such as giving a success badge for the relevant behavior if it reaches someone. Individual phone calls are also included in the intervention program.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Health Protection and Promotion Training Program under the Leadership of a Public Health Nurse
Description: Multiple teaching methods will be used throughout 12 weeks; interactive group trainings on health protection and promotion issues and health seeking behavior methods, demonstration and demonstration using Google Fit and E-Nabiz mobile applications and downloading the applications to their phones, establishing WhatsApp groups to interact with nurses, encouraging physical activity using the Google Fit mobile application. To achieve any of the Health Protection and Development Training Program targets by walking with the nurse, taking individual phone calls regarding health protection and promotion issues, E-Nabiz and Google Fit mobile applications, receiving questions and opinions and giving guidance, holding group meetings in order to provide social interaction and social interaction. It consists of interventions such as giving a success badge for the relevant behavior. Individual phone calls are also included in the intervention program.